The Journal of Urology
Volume 181, Issue 3 , Pages 1028-1034 , March 2009

Genetic Deficiency of Complement Isoforms C4A or C4B Predicts Improved Survival of Metastatic Renal Cell Carcinoma

Received 25 July 2008

References 

  1. Figlin RA. Renal cell carcinoma: management of advanced disease. J Urol. 1999;161:381
  2. Franzke A, Peest D, Probst-Kepper M, Buer J, Kirchner GI, Brabant G, et al. Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancer. J Clin Oncol. 1999;17:529
  3. Yang JC, Hughes M, Kammula U, Royal R, Sherry RM, Topalian SL, et al. Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis. J Immunother. 2007;30:825
  4. Ellerhorst JA, Hildebrand WH, Cavett JW, Fernandez-Vina MA, Hodges S, Poindexter N, et al. Heterozygosity or homozygosity for two HLA class II haplotypes predict favorable outcomes for renal cell carcinoma treated with cytokine therapy. J Urol. 2003;169:2084
  5. Blanchong CA, Chung EK, Rupert KL, Yang Y, Yang Z, Zhou B, et al. Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4. Int Immunopharmacol. 2001;1:365
  6. Isenman DE. C4. In:  Morley BJ,  Walport MJ editor. The Complement FactsBook. San Diego: Academic Press; 2000;p. 95–103
  7. Yang Y, Chung EK, Zhou B, Lhotta K, Hebert LA, Birmingham DJ, et al. The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun. 2004;7:98
  8. Gilliam BE, Wolff AE, Moore TL. Partial C4 deficiency in juvenile idiopathic arthritis patients. J Clin Rheumatol. 2007;13:256
  9. Chung EK, Yang Y, Rupert KL, Jones KN, Rennebohm RM, Blanchong CA, et al. Determining the one, two, three, or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins. Am J Hum Genet. 2002;71:810
  10. Lewis MJ, Botto M. Complement deficiencies in humans and animals: links to autoimmunity. Autoimmunity. 2006;39:367
  11. Prodeus AP, Goerg S, Shen LM, Pozdnyakova OO, Chu L, Alicot AM, et al. A critical role for complement in maintenance of self-tolerance. Immunity. 1998;9:721
  12. Carroll MC. A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol. 2004;4:825
  13. Mauff G, Luther B, Schneider PM, Rittner C, Stradmann-Bellinghausen B, Dawkins R, et al. Reference typing report for complement component C4. Exp Clin Immunogenet. 1998;15:249
  14. Gogas H, Ioannovich J, Dafni U, Stavropoulou-Giokas C, Frangia K, Tsoutsos D, et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med. 2006;354:709

 Study received M. D. Anderson Cancer Center institutional review board approval.

 Supported by National Institutes of Health CA111369 (JAE).

 The contents of this work are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.

PII: S0022-5347(08)03040-1

doi: 10.1016/j.juro.2008.11.013

The Journal of Urology
Volume 181, Issue 3 , Pages 1028-1034 , March 2009

Article Tools

* Image Usage & Resolution